What is erythema toxicum neonatorum and how should it be managed in a newborn?

Erythema Toxicum Neonatorum

Erythema toxicum neonatorum (ETN) is a benign, self-limited rash requiring no treatment beyond parental reassurance—observation alone is appropriate as it resolves spontaneously within one week without sequelae. 1, 2, 3

What is Erythema Toxicum Neonatorum?

ETN is one of the most common benign newborn rashes, presenting with characteristic erythematous macules, papules, wheals, and pustules that typically appear within the first 48-72 hours of life 1, 2, 3. The condition affects approximately 16-21% of newborns, with higher prevalence in certain populations 4, 5.

Clinical Features

• Lesion morphology: Erythematous macules, papules, wheals, and sterile pustules containing predominantly eosinophils 2, 6
• Distribution: Primarily affects the face, trunk, buttocks, and proximal extremities; rarely involves palms and soles 7, 5
• Timing: Usually evident within first 48 hours of life, rarely present at birth 2, 6
• Duration: Transient rash that resolves spontaneously over the course of one week without leaving any marks or complications 1, 2, 3

Predisposing Factors

ETN is more common in:

• Caucasian neonates (statistically significant association) 4, 5
• Male infants 4
• Term infants with higher gestational age and birthweight (suggesting immune system maturity plays a role) 4, 5
• Vaginally delivered infants (compared to cesarean section) 5
• Healthy newborns with 1-minute Apgar scores of 8-10 4
• Infants not requiring NICU admission 4
• Seasonal variation: Less frequent in winter months 4

Management Approach

No Active Treatment Required

The cornerstone of management is parental reassurance and observation—no medical intervention is necessary. 1, 3

• Do not prescribe topical medications, antibiotics, or any other treatments as ETN is self-limited and resolves without intervention 1, 2, 3
• Educate parents that this is a benign condition that will disappear on its own within approximately one week 1, 2, 3
• No follow-up is required unless the rash persists beyond expected timeframe or clinical picture changes 3

Critical Differential Diagnosis

The key clinical responsibility is distinguishing ETN from infectious conditions that require urgent treatment:

• Suspect infection if: Pustules or vesicles occur in an infant who is not well-appearing, has fever, or has risk factors for congenital infection 1
• Congenital infections to exclude:
  • Bacterial sepsis: Requires blood cultures and empiric antibiotics if systemically unwell 1
  • Candida infection: Consider if persistent or atypical distribution 3
  • Congenital syphilis: Look for copper-red maculopapular lesions on palms/feet that peel and crust 1
  • Congenital cytomegalovirus: May present with petechiae from thrombocytopenia and can cause sensorineural hearing loss 1
  • Herpes simplex virus: Requires immediate antiviral therapy if suspected 3

Diagnostic Confirmation

• Clinical diagnosis is sufficient in typical presentations with characteristic appearance, distribution, and timing 1, 3
• Wright stain of pustule contents shows abundant eosinophils if confirmation needed, distinguishing it from infectious pustules which show neutrophils and organisms 2, 6
• No laboratory workup is needed for classic presentations in well-appearing infants 3

Common Pitfalls to Avoid

• Do not confuse with transient neonatal pustular melanosis (TNPM): TNPM is present at birth, has hyperpigmented macules after pustules resolve, and is more common in African American infants 1, 7
• Do not mistake for neonatal acne: Milia are present at birth (ETN is not), and neonatal acne presents as comedones rather than pustules on an erythematous base 1, 7
• Do not overlook signs of systemic illness: Any infant with pustules who appears unwell requires immediate evaluation for sepsis 1, 3
• Avoid unnecessary antibiotic treatment: ETN pustules are sterile and eosinophilic, not bacterial 2, 6